Abstract:DNA is commonly known as the "molecule of life" because it holds the genetic instructions for all living organisms on Earth. The utilization of modified nucleosides holds the potential to transform the management of a wide range of human illnesses. Modified nucleosides and their role directly led to the 2023 Nobel prize. Acyclic nucleosides, due to their distinctive physiochemical and biological characteristics, rank among the most adaptable modified nucleosides in the field of medicinal chemistry. Acyclic nucleosides are more resistant to chemical and biological deterioration, and their adaptable acyclic structure makes it possible for them to interact with various enzymes. A phosphonate group, which is linked via an aliphatic functionality to a purine or a pyrimidine base, distinguishes acyclic nucleoside phosphonates (ANPs) from other nucleotide analogs. Acyclic nucleosides and their derivatives have demonstrated various biological activities such as anti-viral, anti-bacterial, anti-cancer, anti-microbial, etc. Ganciclovir, Famciclovir, and Penciclovir are the acyclic nucleoside-based drugs approved by FDA for the treatment of various diseases. Thus, acyclic nucleosides are extremely useful for generating a variety of unique bioactive chemicals. Their biological activities as well as selectivity is significantly influenced by the stereochemistry of the acyclic nucleosides because chiral acyclic nucleosides have drawn a lot of interest due to their intriguing biological functions and potential as medicines. For example, tenofovir's ( R ) enantiomer is roughly 50 times more potent against HIV than its ( S ) counterpart. We can confidently state, "The most promising developments are yet to come in the realm of acyclic nucleosides!" Herein, we have covered the most current developments in the field of chemical synthesis and therapeutic applications of acyclic nucleosides based upon our continued interest and activity in this field since mid-1990's.

Efficient one-pot process for synthesis of antiviral drug Ganciclovir

Accelerated Effect on Mitsunobu Reaction Via Bis-N-tert-butoxycarbonylation Protection of 2-Amino-6-chloropurine and Its Application in a Novel Synthesis of Penciclovir

Efficient one-pot process for synthesis of antiviral drug amantadine hydrochloride

Expedient Synthesis of Antiviral Drug Molnupiravir from D-Ribose and Cytosine

“One-Pot” Synthesis of Molnupiravir from Cytidine

Acid‐Promoted Cyclization Reaction of the Guanine Base with 1,1,3,3‐Tetramethoxypropane: A Method for the Preparation of M1dG and its Derivatives

Late-Stage Functionalization of Guanine-Based Nucleosides, Nucleotides, and Oligonucleotide: Synthesis and Derivatization of Tricyclic Nucleoside Analogues

"Guanidine hydrochloride assisted one-pot synthesis of 2-amino-4,6-disubstituted-3-cyanopyridine derivatives: a sustainable and greener strategy with catalyst recyclability"

Synthesis of Acyclovir, Ganciclovir and Their Prodrugs: A Review

Recent Advances in the Synthesis of Acyclic Nucleosides and Their Therapeutic Applications

A New Method to Synthesize Famciclovir

An Efficient Synthesis of the Bicyclic Darunavir Side Chain Using Chemoenzymatic Catalysis

Additive-controlled asymmetric iodocyclization enables enantioselective access to both α- and β-nucleosides

One-Pot Assembly for Synthesis of 1,4-Dihydropyridine Scaffold and Their Biological Applications

A Straightforward Entry to Chiral Carbocyclic Nucleoside Analogues Via the Enantioselective [3+2] Cycloaddition of Α-Nucleobase Substituted Acrylates

First enzymatic galactosylation of acyclic nucleoside drugs by β-galactosidase: Synthesis of water-soluble β-D-galactosidic prodrugs

One-Pot Sustainable Synthesis of Highly Substituted Pyrimidines via Acceptorless Dehydrogenative Annulation of Alcohols Using Pincer Ni(II)-NNS Catalysts

Direct and Catalytic C-Glycosylation of Arenes: Expeditious Synthesis of the Remdesivir Nucleoside

Improved Synthesis of Penciclovir

Palladium-Catalyzed One-Pot Synthesis of N -Formylaniline Derivatives Using Oxalic Acid as a Dual Carbon Monoxide and Hydrogen Donor

Asymmetric Transfer Hydrogenation Via Dynamic Kinetic Resolution for the Construction of Carbocyclic N3-Purine Nucleosides